Impact of the Model for End-Stage Liver Disease Allocation Policy on the Use of High-Risk Organs for Liver Transplantation

Gastroenterology

Volumn 135, Issue 5, 2008, Pages 1568-1574

  Volk, Michael L ^a,c   Lok, Anna S F ^a   Pelletier, Shawn J ^a   Ubel, Peter A ^b,c   Hayward, Rodney A ^b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GRAFT FAILURE; HEALTH CARE POLICY; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MEDICAL RECORD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL;

EID: 55249122655     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.08.003     Document Type: Article

References (29)

1. IOM. Organ procurement and transplantation: assessing current policies and the impact of the DHHS final rule (2000), National Academies Press, Washington, DC
2. Kamath P.S., Wiesner R.H., Malinchoc M., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33 (2001) 464-470
3. Ubel P.A., and Loewenstein G. Distributing scarce livers: the moral reasoning of the general public. Soc Sci Med 42 (1996) 1049-1055
4. Merion R.M., Schaubel D.E., Dykstra D.M., et al. The survival benefit of liver transplantation. Am J Transplant 5 (2005) 307-313
5. Feng S., Goodrich N.P., Bragg-Gresham J.L., et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 6 (2006) 783-790
6. Segev D.L., Maley W.R., Simpkins C.E., et al. Minimizing risk associated with elderly liver donors by matching to preferred recipients. Hepatology 46 (2007) 1907-1918
7. Avolio A.W., Agnes S., Gasbarrini A., et al. Allocation of nonstandard livers to transplant candidates with high MELD scores: should this practice be continued?. Transplant Proc 38 (2006) 3567-3571
8. Amin M.G., Wolf M.P., TenBrook Jr. J.A., et al. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl 10 (2004) 1468-1475
9. Schaubel D.E., Sima C.S., Goodrich N.P., et al. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 8 (2008) 419-425
10. UNOS. Policy 3.6, organ distribution: allocation of livers (2006), UNOS, Richmond, VA
11. Allison P.D. Missing data (2002), Sage Publications, Thousand Oaks, CA
12. Roberts J.P., Dykstra D.M., Goodrich N.P., et al. Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant 6 (2006) 2470-2475
13. Biggins S.W., and Bambha K. MELD-based liver allocation: who is underserved?. Semin Liver Dis 26 (2006) 211-220
14. MacKinnon D.P., Fairchild A.J., and Fritz M.S. Mediation analysis. Annu Rev Psychol 58 (2007) 593-614
15. Maluf D.G., Edwards E.B., and Kauffman H.M. Utilization of extended donor criteria liver allograft: is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient?. Transplantation 82 (2006) 1653-1657
16. Rodriguez-Luna H., Vargas H.E., Moss A., et al. Regional variations in peer reviewed liver allocation under the MELD system. Am J Transplant 5 (2005) 2244-2247
17. Bravata D.M., Olkin I., Barnato A.E., et al. Health-related quality of life after liver transplantation: a meta-analysis. Liver Transpl Surg 5 (1999) 318-331
18. Ratcliffe J., Longworth L., Young T., et al. Assessing health-related quality of life pre- and post-liver transplantation: a prospective multicenter study. Liver Transpl 8 (2002) 263-270
19. Saab S., Ibrahim A.B., Shpaner A., et al. MELD fails to measure quality of life in liver transplant candidates. Liver Transpl 11 (2005) 218-223
20. Kanwal F., Hays R.D., Kilbourne A.M., et al. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease?. Am J Gastroenterol 99 (2004) 1726-1732
21. Axelrod D.A., Schnitzler M., Salvalaggio P.R., et al. The economic impact of the utilization of liver allografts with high donor risk index. Am J Transplant 7 (2007) 990-997
22. Foley D.P., Fernandez L.A., Leverson G., et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg 242 (2005) 724-731
23. Redelmeier D.A., and Shafir E. Medical decision making in situations that offer multiple alternatives. JAMA 273 (1995) 302-305
24. Gilovich T., Griffin D.W., and Kahneman D. Heuristics and biases: the psychology of intuitive judgement (2002), Cambridge University Press, Cambridge, UK
25. Cialdini R.B. Influence: science and practice. 4th ed. (2001), Allyn and Bacon, Boston, MA
26. Axelrod D.A., Koffron A.J., Baker T., et al. The economic impact of MELD on liver transplant centers. Am J Transplant 5 (2005) 2297-2301
27. Jones I.R., Berney L., Kelly M., et al. Is patient involvement possible when decisions involve scarce resources?. A qualitative study of decision-making in primary care. Soc Sci Med 59 (2004) 93-102
28. Workgroup on expanded criteria organs for liver transplantation. Liver Transpl 11 (2005) 1184-1192
29. Ross L.F., Zenios S., and Thistlethwaite Jr. J.R. Shared decision making in deceased-donor transplantation. Lancet 368 (2006) 333-337